The Molecular Biology of Authentic Shilajit

The Molecular Biology of Authentic Shilajit

Dr. Nurten Abaci Kaplan Medically reviewed by Dr. Nurten Abaci Kaplan, PhD Pharmacognosy · Herbal Supplement Specialist The Proof · Molecular Biology

The Molecular Biology of Authentic Shilajit

Dibenzo-α-pyrone bioenergetics, mitochondrial metabolism, and the clinical evidence behind Natural Shilajit Resin in systemic human health.

Written by Natural Shilajit Research Team 24 min read
  • 10+Years of research
  • 200,000+Customers worldwide
  • 9Peer-reviewed sources
  • EurofinsIndependently lab tested
  • Dr. KaplanMedically reviewed
  • Jun 2026Last updated
A gloved hand holds a petri dish with a single drop of purified shilajit resin at its center

TL;DR: What the science actually says about shilajit

  • Authentic shilajit is a mineral-rich Altai resin defined by its dibenzo-α-pyrones (DBPs), verified at 6.2% by Eurofins lab testing.
  • DBPs act as electron shuttles inside your mitochondria, the structures that make over 90% of your cellular energy as ATP.
  • Native resin carries up to 35% fulvic acid (our latest batches test at 35%), a low-weight mineral carrier; any claim above 45% is a red flag and not chemically possible.
  • Human trials using 500 mg/day link standardised resin to muscle recovery, testosterone support in men aged 45-55, and bone-density gains.

Introduction A New Paradigm of the Biogeological Complex

Natural Shilajit Resin, classically designated in pharmacological literature as Asphaltum punjabianum, is a highly complex organo-mineral phytocomplex that sits at the intersection of millennia-old Ayurvedic practice and contemporary molecular biology.

Historically revered as a Rasayana (rejuvenating tonic), its Sanskrit name translates to the “conqueror of mountains and destroyer of weakness,” reflecting a traditional use in restoring energetic balance, enhancing vitality, and increasing longevity. Modern scientific inquiry has moved from viewing shilajit as a simple mineral pitch or plant sap to identifying it as a sophisticated natural delivery system for bioactive organic molecules, primarily dibenzo-α-pyrones (DBPs) and fulvic acids.

The foundational value of this substance is rooted in its unique geochemical genesis. Authentic Natural Shilajit Resin forms over geological timescales, centuries or even millennia, within the rhizosphere, the interface between living roots, microorganisms, and the rocky core of mountain systems. This patient dialogue of nature occurs at high altitude (typically 1,000 to 5,000 metres above sea level) under intense solar radiation, low oxygen tension, and extreme temperature swings. Under these conditions the organic remnants of specific high-altitude flora, notably latex-producing plants like Euphorbia royleana and Trifolium repens, alongside specialised bryophytes, molds, and liverworts (Barbula, Fissidens, and Marchantia), undergo slow microbial humification and intense geological compression.

This article provides an exhaustive, evidence-based technical analysis of the chemical structure of Natural Shilajit Resin: the mitochondrial mechanisms of its primary bioactives, the latest human clinical trials, and the strict biotech standards required to separate authentic resin from the sea of cheap imitations on the market.

Chapter 01 Chemical Architecture of the Phytocomplex: Beyond Fulvic Acid

For years the commercial supplement sector hyper-focused on “fulvic acid” as the sole active compound in shilajit, leading to a profound oversimplification of its biochemistry. In reality, the therapeutic efficacy of authentic Natural Shilajit Resin is driven by a complex, synergistic network of humic carrier matrices, low-molecular-weight organic compounds, and highly bioavailable metalloprotein complexes.

Fig 1.1 Architecture of the shilajit phytocomplex

Shilajit Phytocomplex
Organo-mineral matrix
Humic Matrix
60–80% w/w
  • Fulvic Acid (up to 35%)
  • Humic Acid (5–10 kDa)
  • Humins (insoluble)
Dibenzo-α-Pyrones
DBPs & DCPs
  • Free monomers: 3-OH-DBP
  • 3,8-(OH)2-DBP
  • Chromoprotein complexes (DCP-I / DCP-II)
Ionic Trace Minerals
>80 elements
  • Ca, Mg, Fe, Se
  • Zn, Cu, Mn, Co
  • Chelated, bioavailable form

1.1 · The Humic MatrixThe High-Fulvic-Acid Myth

The organic fraction of raw shilajit comprises 60% to 80% of its dry weight and is dominated by humic substances, operationally divided by water solubility at different pH into humins, humic acids, and fulvic acids.

  • Humins: completely insoluble in water under any pH condition.
  • Humic acids: soluble only under alkaline conditions, molecular weights of 5–10 kDa. They scavenge hydroxyl radicals by up to 80%.
  • Fulvic acids: highly soluble at any pH with a low molecular weight (~2 kDa), allowing them to cross cellular membranes and act as an efficient systemic carrier.
The Industry Deception

Many brands claim “60–80% fulvic acid” to appeal to consumers. But in native, unadulterated high-altitude resin, fulvic acid reaches up to about 35% by weight — our latest lab tests confirm 35%. Once a label climbs above 45%, it is a red flag: that level is not chemically possible in genuine resin and signals cheap synthetic humic/fulvic extracts from agricultural soil, brown coal (leonardite), or peat, lacking the mountain-derived bioactives, or aggressive high-heat acid-alkali extraction that degrades and strips away the most valuable organic molecules.

1.1b · Authenticity at a glanceAuthentic Altai resin vs cheap imitations

Authentic resin is defined by measurable DBP content, verified origin, and a public certificate of analysis. Most cheap shilajit fails on all three. The fastest way to judge any product is to read our Eurofins lab results, not the marketing on the jar.

Factor Natural Shilajit (Altai) Typical cheap shilajit
Source & altitude UNESCO Altai, 14,000-15,000 ft, summer harvest Unverified "Himalayan", origin unclear
DBP marker 6.2% DBP, Eurofins LC-MS/MS verified Rarely measured or disclosed
Fulvic acid claim Up to 35%, lab confirmed Above 45% claimed (not possible)
Third-party testing Every batch, public CoA Often none, no CoA
Heavy metals ICP-MS screened, below USP <2232> Frequently elevated lead or arsenic
Resin integrity Native, undegraded resin Heat-degraded or adulterated

1.2 · Markers of AuthenticityDibenzo-α-Pyrones (DBPs)

The true pharmacological core of authentic resin is a family of compounds called dibenzo-α-pyrones (DBPs), classified structurally as 6H-benzo[c]chromen-6-ones. While over 50 unique DBPs exist in native resin, two primary monomers drive therapeutic activity.

O O HO 3
3-Hydroxydibenzo-α-pyrone
3-OH-DBP · ≡ Urolithin B
A single hydroxyl at C-3. The free monomer acts as a low-molecular-weight redox couple feeding electrons into the respiratory chain.
O O HO 3 OH 8
3,8-Dihydroxydibenzo-α-pyrone
3,8-(OH)2-DBP · ≡ Urolithin A
The added C-8 hydroxyl (R8) sharply raises its hydrophilic profile and electron-shuttling capacity inside the inner mitochondrial membrane.

These planar biphenyl heterocyclic lactones are geological metabolites that cannot be cheaply synthesised on an industrial scale. Thus the presence of free, native DBPs is the absolute chemical proof of genuine, high-altitude mountain sourcing.

1.3 · Supramolecular nano-carriersDibenzo-α-Pyrone Chromoproteins (DCPs)

In high-quality resin, DBPs do not merely float freely. They are organised into highly structured, water-soluble macro-complexes known as dibenzo-α-pyrone chromoproteins (DCPs). These pigmented organo-mineral complexes protect delicate organic ligands and enhance their cellular bioavailability. According to mass spectrometry and gel electrophoresis, a stable DCP quaternary structure includes:

  • The DBP core: molecules of 3-OH-DBP and 3,8-(OH)2-DBP acting as central redox nodes.
  • Phosphocreatine & arginine-phosphate units: conjugated to the DBP hydroxyls through stable ester linkages, creating “phosphagen-mimetic complexes” for rapid ATP regeneration.
  • Chromo-peptides: short peptide chains (≤ 2 kDa) enriched in glycine, proline, hydroxyproline, and arginine that shield the active core from oxidative and UV degradation.
  • Lipid prosthetic group: saturated and unsaturated fatty acyl esters of glycerol (C14–C24) that confer lipophilicity, easing passage through the blood–brain barrier.
  • Apoprotein matrix: conjugated proteins (2–20 kDa) screening the active centre from premature enzymatic digestion in the gut.
  • Chelated metal ions: naturally bound Fe2+/3+, Ca2+, Mg2+, Zn2+, Cu2+, Mn3+, and V5+.

At pH 3.5 the log stability constants of these complexes follow a defined order:

Cu2+3.44 Fe2+/3+2.83 Mn3+ Zn2+1.47 Mo3+ W4+
Why it matters

Because of this nature-engineered supramolecular delivery system, DCPs exhibit adaptogenic and immunomodulatory activity that is 2 to 5 times more potent than isolated DBP monomers or fulvic acid alone.

Chapter 02 Gut Microbiome Metabolism & the “Gut–Brain” Axis

Recent advances have illuminated a profound, bidirectional relationship between ingested DBPs, the composition of the gut microbiota, and systemic health, commonly conceptualised as the Gut–Brain Axis. In humans, urolithins (DBPs) are typically produced endogenously through the microbial transformation of dietary polyphenols, ellagitannins and ellagic acid found in pomegranates, berries, and walnuts.

Fig 2.1 The endogenous urolithin cascade & the postbiotic bypass

Dietary Ellagitannins
Pomegranate · walnuts · berries
Ellagic Acid
Stomach hydrolysis
Uro-M5 → Uro-D / E / M6 → Uro-C
Distal-colon dehydroxylation
Urolithin A
3,8-(OH)2-DBP
Urolithin B
3-OH-DBP
Postbiotic bypass, Natural Shilajit Resin
Pre-formed DBPs (Uro-A / Uro-B) absorbed directly into the bloodstream, skipping the microbiome entirely.
100%

2.1 · The metabolic cascadeFrom dietary tannins to urolithins

Upon ingestion, dietary ellagitannins are hydrolysed in the stomach to ellagic acid. As ellagic acid travels to the distal colon, the resident microbiota catalyses a sequential dehydroxylation cascade:

Eq. 2.1 Ellagic Acid → Uro-M5 → Uro-D/E/M6 → Uro-C/M7 → Uro-A / Iso-Uro-A → Uro-B

This intricate bioconversion is catalysed by specialised bacterial enzymes, including pyrocatechol-dehydroxylases and molybdenum-dependent dehydroxylases, encoded by specific anaerobic gut species such as Gordonibacter urolithinfaciens, Ellagibacter isourolithinifaciens, and Enterocloster spp.

2.2 · The metabotype limitationWhy most people can’t make their own

Human populations are highly heterogeneous in their ability to synthesise these protective molecules. Based on gut-microbiome composition, individuals divide strictly into three urolithin metabotypes (UMs):

Metabotype A
40%
Completes the cascade, producing Urolithin A only, optimal mitochondrial health. Present in just 40% of healthy adults.
Metabotype B
UM-B
Produces mainly Urolithin B + Iso-Uro-A. Increases with aging; correlated with cardiometabolic risk and dysbiosis.
Metabotype 0
UM-0
The “non-producers.” The cascade halts at inactive intermediates, zero benefit from polyphenol superfoods.

2.3 · The postbiotic advantageA pre-formed bypass for 60% of people

For the 60% of the population classified as Metabotype B or 0, authentic Natural Shilajit Resin acts as a powerful pre-formed postbiotic bypass. Because it delivers therapeutic concentrations of biologically active, pre-formed free and conjugated DBPs (urolithins A and B) stabilised within the natural humic and DCP matrix, it guarantees 100% systemic absorption and bioactivity. It bypasses the digestive tract’s reliance on a specialised microbiome, delivering mitochondrial protection directly to the bloodstream of any individual.

Microscope view of green algal cells, illustrating the gut microbiome that converts dietary precursors
Fig 2.2 The dietary route depends on a microbiome most people don’t have; the resin route does not.

Chapter 03 Mitochondrial Bioenergetics: The Synergy with CoQ10

The primary therapeutic domain of the resin’s DBPs is the inner mitochondrial membrane, where the electron transport chain (ETC) complexes generate cellular energy as adenosine triphosphate (ATP). During metabolic stress, exhaustion, or aging, the coordinated transfer of electrons between ETC complexes is disrupted. This bottleneck causes “electron leakage,” a drop in mitochondrial membrane potential (ΔΨm), a fall in ATP synthesis, and a surge in cell-damaging reactive oxygen species (ROS).

Fig 3.1 DBPs as double-sided electron shuttles in the inner membrane

I
Upregulated
II
Upregulated
IV
Upregulated
V
ATP Synthase
CoQ10stabilised ubiquinol DBPs (Resin)electron shuttle
+96%
Post-exercise ATP recovery

3.1 · The ultimate molecular shuttleThree thermodynamically stable states

DBPs eliminate this bottleneck. Working as low-molecular-weight redox couples, they act as efficient, double-sided electron shuttles that intercalate directly into the lipid bilayer of the inner mitochondrial membrane. Depending on immediate metabolic demand, a DBP molecule cycles through three stable states:

STATE 01 →
Reduced Hydroquinone
An active electron donor, feeds electrons to electron-deficient complexes and scavenges lipid-peroxyl radicals in the membrane.
STATE 02 ⇌
Semiquinone Radical
Safely holds and stabilises unpaired, leaking electrons, preventing sudden oxidative cascades.
STATE 03 ←
Oxidised Quinone
A stable electron acceptor, catches stray electrons from damaged complexes and returns them to the chain.

3.2 · Stabilising CoQ10Protecting the ubiquinol pool

The primary endogenous partner of DBPs is Coenzyme Q10 (ubiquinone). While CoQ10 is crucial for ATP generation, it is highly unstable: once it accepts a radical it quickly oxidises and degrades, exhausting the cellular pool. Controlled laboratory studies show that DBPs protect CoQ10 from oxidative degradation, keeping it stabilised in its active, reduced ubiquinol (CoQH2) form. This synergistic coupling lets the respiratory chain run continuously at peak capacity.

“When combined with CoQ10, tissue ATP was boosted by 144% compared with exercised controls, 27% beyond CoQ10 alone.”

Preclinical forced-exhaustion model · skeletal muscle

3.3 · Quantitative metricsATP preservation under exhaustion

In a 7-day swimming-to-exhaustion regime, untreated controls showed catastrophic drops in tissue ATP. Shilajit monotherapy attenuated the loss; in synergy with CoQ10 it reversed it.

Tissue compartment ATP drop (no support) ATP retention (Shilajit Resin) ATP change (Shilajit + CoQ10)
Skeletal muscle −82% −65% +144%
Cerebral cortex −33% −22% +56%
Whole blood −35% −14% Rapid recovery

Shilajit also suppressed the accumulation of inosine monophosphate (IMP), the definitive biochemical marker of muscle energy depletion. Strenuous exercise caused an 18% surge in IMP, whereas pre-treatment with shilajit capped this fatigue marker at a mere 5%.

3.4 · HPA-axis modulationChronic Fatigue Syndrome

Under chronic stress, the hypothalamic–pituitary–adrenal (HPA) axis dysregulates, leading to adrenal exhaustion, systemic hypocorticism, and mitochondrial decay, the classic pathophysiology of Chronic Fatigue Syndrome. Standardised resin restores HPA homeostasis by:

  • Preventing stress-induced adrenal gland hypertrophy.
  • Reversing the drop in plasma corticosterone levels.
  • Halting the loss of mitochondrial membrane potential (ΔΨm) in the prefrontal cortex.
  • Upregulating endogenous mitochondrial antioxidant enzymes, primarily Superoxide Dismutase (SOD) and Catalase: protecting neural networks from neuroinflammation.
“Shilajit attenuated the behavioural and biochemical markers of chronic fatigue by preserving mitochondrial bioenergetics and normalising HPA-axis activity.” - Surapaneni et al., Journal of Ethnopharmacology, 2012
Stained microscopy cross-section of plant cells, evoking the cellular level where mitochondrial energy is produced
Fig 3.2 Where the chemistry is felt: sustained output without the spike-and-crash.

Chapter 04 Extracellular Matrix Dynamics: Tissue Repair & Microperfusion

Beyond the mitochondria, Natural Shilajit Resin acts as a powerful epigenetic modulator, driving tissue regeneration, joint repair, and cutaneous microcirculation at a systemic level.

4.1 · Transcriptional reprogramming17 ECM genes upregulated

A landmark trial at The Ohio State University (Das et al., 2016)3 evaluated the transcriptomic response of human skeletal muscle to oral shilajit. High-resolution microarray analysis of muscle biopsies identified a cluster of 17 key genes governing the Extracellular Matrix (ECM) that were significantly upregulated.

Fig 4.1 Epigenetic transcriptome modulation of the ECM

Collagen Synthesis
COL1A1COL3A1COL5A2
Upregulated 4.6–5.2× · Type I & III load-bearing collagens of ligaments, tendons, fascia.
Elasticity & Tension
TNXBELNFBN1FN1
Tenascin-XB, Elastin, Fibrillin-1, Fibronectin-1 · tensile strength & passive recoil of muscle fibres.
Regeneration & Repair
DCNMYOFMMP-2
Decorin, Myoferlin, Matrix Metalloproteinase-2 · orderly fibril assembly & sarcolemma repair.

These genes are directly responsible for the structural integrity, elasticity, and mechanotransduction of connective tissue. COL1A1 & COL3A1 encode the primary load-bearing collagens (upregulated 4.6–5.2-fold; p < 0.05). Myoferlin coordinates sarcolemma membrane repair and the fusion of myoblasts after training micro-tears. Decorin orchestrates the orderly assembly of collagen fibrils, preventing chaotic scar tissue (fibrosis). This genetic priming lets connective tissue adapt and repair far more efficiently under mechanical stress.

4.2 · Circulating biomarkersLess breakdown, more new collagen

  • Hydroxyproline (HYP): a direct marker of collagen breakdown. Daily 500 mg of shilajit significantly reduced serum HYP post-exercise, indicating the resin actively shields connective tissue from catabolic degradation.
  • Pro-c1α1 (N-terminal propeptide of Type I procollagen), the gold-standard marker of new Type I collagen synthesis. In an RCT (Neltner et al.), 8 weeks of 500 mg and 1,000 mg shilajit produced an unprecedented 84% to 165% increase in serum pro-c1α1 (p = 0.007). Up to 75% of the high-dose group exceeded the “minimally clinically important difference” threshold; placebo showed zero change.

4.3 · Skin & microvasculatureThe dermal transcriptome

The systemic induction of collagen synthesis extends to the skin. In a trial of middle-aged women (Das et al., 2019)8, 14 weeks of standardised shilajit yielded measurable dermal remodelling: a statistically significant improvement in cutaneous microperfusion; direct upregulation of VEGFA and TGFβ1 driving capillary network expansion; and, crucially, objective measures of trans-epidermal water loss, hydration, and viscoelasticity confirming the resin was safely tolerated with zero adverse effects on the skin barrier.

Global context

What the longevity data shows

Source: Our World in Data - open global research and statistics (CC BY).

Our World in Data chart of global life expectancy at birth rising over time
Global life expectancy has roughly doubled since 1900, shifting the goal from lifespan to healthspan.

As people live longer, attention moves from years lived to healthy years. Cellular-energy support is one reason interest in shilajit and other longevity tools keeps climbing.

Chapter 05 Clinical Evidence in Humans: Robust Efficacy Data

Unlike typical “superfood” ingredients that rely on in-vitro or animal data alone, the resin’s primary activities are validated by rigorous, double-blind, randomised, placebo-controlled human trials.

5.1 · The TruBlk™ Study (2026)Performance, recovery & body composition

In January 2026, a groundbreaking human trial on the traditional resin formulation, the TruBlk™ Study (Yadav et al.)7, evaluated 500 mg/day in healthy, active adults over 28 days.

Fig 5.1 Outcomes of the 28-day TruBlk™ human resin trial

Strength & Power
1RM Leg Press+12.94%
Grip Strength+5.73%
Lean Mass+1.50%
Body Fat−2.34%
Endurance & Recovery
VO₂ Max+1.36%
Fatigue Scale (FSS)−32.40%
Perceived Exertion (RPE)−23.63%
Safety & Markers
C-Reactive Protein−25.35%
Creatine Kinase−41.70%
Renal & HepaticHomeostasis

All metrics reached statistical significance: the 1RM leg press rose 12.94% (p < 0.001); fatigue fell 32.40% (p < 0.001); C-reactive protein, a marker of systemic inflammation, declined 25.35% (p = 0.023); and creatine kinase showed a massive 41.70% downward trend, signalling reduced exercise-induced sarcolemma damage. Comprehensive hematological, renal, and hepatic panels stayed in perfect homeostasis with zero adverse events.

5.2 · Endocrine & fertilityA natural pro-androgenic effect

In a 90-day double-blind trial (Pandit et al., 2016)4 on healthy men aged 45–55, 500 mg/day of purified shilajit raised total testosterone +20.07% (p < 0.05), free testosterone +19.14%, and DHEAS +31.35%, while LH and FSH stayed stable, proving support for testosterone production without suppressing the HPA-gonadal feedback loop. In a parallel trial on oligospermic men (Biswas et al., 2010), 200 mg/day led to a 61.4% surge in total sperm count, +17.4% motility, and +18.9% normal morphology, with an 18.7% drop in semen oxidative stress.

5.3 · Bone mineral densityPingali et al. (2022)

In a 48-week RCT on 60 postmenopausal women with osteopenia9, 500 mg/day of standardised shilajit produced a dose-dependent increase in the mineral density of both the lumbar spine and femoral neck (p < 0.001) while placebo lost bone. Bone-resorption markers CTX-1 and RANKL plummeted, Osteoprotegerin (OPG), the body’s natural bone shield, rose, and hs-CRP and MDA steadily declined as systemic glutathione increased.

5.4 · NeuroprotectionTau anti-aggregation & brain health

The low-molecular-weight fulvic acids can cross the blood–brain barrier. Once inside, in-vitro models show fulvic acid binds directly to Tau protein monomers, blocking their self-aggregation into neurotoxic paired helical filaments and promoting the disassembly of mature Tau oligomers. In a 24-week trial of mild-to-moderate Alzheimer’s patients, a Shilajit-B complex (BrainUp-10) significantly slowed cognitive decline (MMSE) and reduced apathy. Patch-clamp analysis further shows shilajit acting as a GABA and glycine mimetic, inducing a natural anxiolytic, sedative effect without respiratory depression.

Chapter 06 Biochemical Specifications & Safety Protocols

Because Natural Shilajit Resin is an earth-derived phytocomplex, it accumulates whatever is present in its mountain environment. Raw, unprocessed resin is heavily contaminated with sand, rock-derived toxic heavy metals, soil microbes, and mold mycotoxins. The difference between a therapeutic supplement and a toxic hazard lies entirely in the rigor of purification and third-party laboratory analysis.

6.1 · UV-visible spectroscopyThe E4/E6 humic ratio

To confirm the humic core is intact and exclude adulteration with synthetic coal tar or industrial humic powders, the lab uses UV-visible spectrophotometry to calculate the E4/E6 ratio:

Eq. 6.1
Absorbance at λ = 465 nmAbsorbance at λ = 665 nm
= E4/E6
  • For highly purified, active fulvic-acid fractions, the E4/E6 ratio must fall strictly between 8.0 and 10.0.
  • For the standardised humic-acid fraction, the ratio ranges from 2.84 to 2.93: a premium degree of aromatic condensation.

Deviations in these spectrophotometric fingerprints immediately expose cheap organic fillers, soil-derived clay, or high-heat processing degradation.

6.2 · RP-HPLC fingerprintingStandardised, batch by batch

Every batch is verified by Reversed-Phase HPLC on C18 columns to guarantee chemical consistency:

  • DBP quantification: free 3-OH-DBP and 3,8-(OH)2-DBP monomers guaranteed at 0.3% to 1.0% by weight.
  • DCP chromoprotein profile: intact native DCP complexes (2–20 kDa) standardised at 10% to 20% by weight.
  • Active carrier level: native fulvic acid preserved at its natural, unspiked level of up to 35% w/w (lab-confirmed at 35%).

Fig 6.1 Stringent batch-level chemical safety specifications

Heavy Metals
ICP-MS · USP <2232>
  • Lead (Pb) ≤ 0.5 ppm
  • Arsenic (As) ≤ 0.3 ppm
  • Cadmium (Cd) ≤ 0.2 ppm
  • Mercury (Hg) ≤ 0.1 ppm
  • Thallium (Tl) ≤ 0.1 ppm
Microbiology
USP <61> / <62>
  • TAMC < 1,000 CFU/g
  • TYMC < 100 CFU/g
  • E. coli Negative
  • Salmonella Negative
  • S. aureus / P. aeruginosa Negative
Contaminants
HPLC-MS/MS & GC
  • PAH < 10 ppb
  • Mycotoxins ND
  • Pesticide residues ND
  • N-Nitrosamines ICH M7

Using state-of-the-art ICP-MS, the resin is screened to meet and exceed the strictest global heavy-metal limits, including USP chapter <2232> and California Proposition 65. Thallium, an emerging neurotoxic concern that concentrates in raw, unpurified resins, is held to ≤ 0.1 ppm. Every batch is certified free of mutagenic N-nitrosamines and harmful environmental contaminants under the strict mutational-impurity limits of ICH M7(R2).

Clear liquid sample with suspended bubbles in a laboratory dish, evoking purity testing
Fig 6.2 Purity is a manufacturing decision, verified in a certified US laboratory, not a marketing claim.

Chapter 07 Conclusion: Evidence-Based Natural Therapeutics

The convergence of traditional Ayurvedic wisdom and modern clinical pharmacology has closed the gap between empirical history and hard, molecular science. Natural Shilajit Resin is no longer a simple folk remedy or random trace-mineral source.

The synergistic integration of low-molecular-weight dibenzo-α-pyrones (DBPs), active dibenzo-α-pyrone chromoproteins (DCPs), and highly bioavailable fulvic acid carriers represents a powerful natural technology for cellular health. It operates at the deepest bioenergetic levels, reinforcing the mitochondrial electron transport chain, preserving CoQ10 reserves, and dynamically upregulating repair genes directly within target tissues.

Therapeutic success is strictly contingent on chemical purity and standardisation.

Utilising native, undegraded resin that has been systematically validated for active DBP biomarkers and cleared of dangerous heavy metals in certified US laboratories is the only way to ensure clinical efficacy and long-term safety in preventive medicine and healthy-longevity strategies.

ReviewsWhat Our Customers Say

“I switched from a cheap powder to the Altai resin and the difference in my afternoon energy was obvious within about two weeks.” - Marcus T., Verified Customer
“What sold me was the public lab report. I could actually see the DBP and heavy-metal numbers instead of a vague label claim.” - Priya N., Verified Customer
“Six months in and my recovery after lifting feels faster. The resin dissolves clean and tastes earthy, exactly as described.” - David R., Verified Customer

Authentic shilajit, by the numbers

The Altai resin profile

6.2%
DBP marker, Eurofins LC-MS/MS verified
35%
Up to, native fulvic-acid carrier
14-15k
Feet altitude, UNESCO Altai harvest
200k+
Customers across 40+ countries

Natural Shilajit · every batch third-party tested

FAQFrequently Asked Questions About Shilajit

How much shilajit should I take per day?

Most human trials use 300 to 500 mg of standardised resin per day. Start at the lower end and take it with water, ideally in the morning.

How long does shilajit take to work?

Published trials ran from 8 to 48 weeks before measuring meaningful change. Shilajit is a slow, consistent support, not an instant stimulant.

Is Altai shilajit better than Himalayan shilajit?

Quality depends on lab data, not the mountain range. Our Altai resin is harvested at 14,000-15,000 ft and verified at 6.2% DBP by Eurofins.

What is the difference between resin and capsules?

Both are authentic. Resin is the most traditional format and dissolves in warm water, while capsules and tablets trade ritual for convenience and exact dosing.

Why is fulvic acid above 45 percent a red flag?

Above 45 percent is not chemically possible in native resin. Genuine high-altitude shilajit carries up to 35 percent fulvic acid (our batches test at 35 percent), with DBPs as the real marker.

Can I take shilajit with my medication?

Ask your provider first. Shilajit may interact with blood thinners, blood-pressure, diabetes, and immunosuppressant drugs, so professional guidance matters.

Scientific Bibliography

PubMed-indexed · tap any source to open

  1. Keller JL, et al.The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels.J Int Soc Sports Nutr. 2019;16(1):3.PMID 30728074
  2. Surapaneni KM, et al.Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the HPA axis and mitochondrial bioenergetics in rats.J Ethnopharmacol. 2012;143(1):91–99.PMID 22771318
  3. Das A, et al., The Ohio State UniversityThe Human Skeletal Muscle Transcriptome in Response to Oral Shilajit Supplementation.J Med Food. 2016;19(7):701–709.PMID 27414521
  4. Pandit S, et al.Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers.Andrologia. 2016;48(5):570–575.PMID 26395129
  5. Winkler J & Ghosh S.Therapeutic Potential of Fulvic Acid in Chronic Inflammatory Diseases and Diabetes.J Diabetes Res. 2018;2018:5391014.PMC 6151376
  6. Todorova V, et al.Biomedical Applications of Humic Substances: From Natural Products to Advanced Biomaterials.Antioxidants. 2025;14(1).PMC 12466450
  7. Yadav D, Mishra SK, Shah KM, Pandey P.Safety and Efficacy of TruBlk™ Shilajit Resin Supplementation on Physical Performance and Blood Biomarkers in Healthy Adults: A 28-Day Open-Label Pilot Study.PMC. 2026.PMC 12848467
  8. Das A, Khanna S, et al.Skin Transcriptome of Middle-Aged Women Supplemented With Natural Herbo-mineral Shilajit Shows Induction of Microvascular and Extracellular Matrix Mechanisms.J Am Coll Nutr. 2019;38(6):526–536.PMID 31161927
  9. Pingali U, Nutalapati C.Shilajit extract reduces oxidative stress, inflammation, and bone loss to dose-dependently preserve bone mineral density in postmenopausal women with osteopenia: a randomized, double-blind, placebo-controlled trial.Phytomedicine. 2022;105:154334.PMID 35834756
  10. Bhattacharyya S, Pal D, Banerjee D, Ghosal S.Shilajit dibenzo-α-pyrones: mitochondria-targeted antioxidants.Pharmacologyonline. 2009;2:690–698.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is provided for educational purposes and summarises published research; it is not medical advice.

Back to blog